Evidence map›Paper›PMID 39974593›Full record

ArticleMediterranean journal of rheumatology2024

Exploring the Cutting Edge: A Recap of EULAR & ACR 2023 Highlights for Spondyloarthritis, including Psoriatic Arthritis.

Nafsika Gerolymatou, Paraskevi V Voulgari

Abstract read
In one paragraph

Article in Mediterranean journal of rheumatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nafsika GerolymatouDepartment of Rheumatology, School of Health Sciences, Faculty of Medicine, University of Ioannina, Ioannina, Greece.
Paraskevi V VoulgariDepartment of Rheumatology, School of Health Sciences, Faculty of Medicine, University of Ioannina, Ioannina, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As the field of rheumatology continues to advance, the European Alliance of Associations for Rheumatology (EULAR) and the American College of Rheumatology (ACR) annual meetings stand as pivotal events, showcasing the latest research, treatments, and insights into various rheumatic diseases. Among these, Inflammatory Spondyloarthritis presents a unique challenge, characterised by its elusive diagnostic markers and diverse clinical manifestations. In this article, we delve into the highlights and findings from EULAR 2023 and ACR 2023, shedding light on the latest advancements in understanding and managing these complex rheumatic conditions.

Indexed as

ACREULARPsASpA

Identifiers

PMID39974593
PMCPMC11834990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.